Emyria Ltd (EMD)

EMD Chart

vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Advanced

Show News Mov Avgs 9-day 10-day 20-day 30-day 50-day 100-day 150-day 200-day Mov Avgs 9-day 21-day 30-day 200-day Simple Exponential Weighted Simple Exponential Weighted vs Index S&P/ASX 20 S&P/ASX 50 S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 All Ordinaries Small Ordinaries All Technology Consumer Staples Energy Financials Health Care Industrials Info Technology Materials Real Estate Comm. Services Utilities

Mov Avgs 10-day 20-day 30-day 50-day 100-day 150-day 200-day 9/21 Cross 10/30 Cross Golden Cross Vol RSI BB

Day 3m 6m 1yr 5yr 10yr

EMD's Principal Activity is the provide care for its patients through Emeralds specialist clinics whilst gathering Real-World-Evidence (RWE) insights in relation to novel therapies such as medicinal cannabinoid.

Announcements

Company Overview

Dividend History

Directors & Management

Name	Title	Since	Bio
Sir John Tooke	Non-Executive Director	Feb 2020	Sir John Tooke Non-Executive Director Sir Tooke is Executive Chairman of Academic Health Solutions, a start-up Group offering advice to clients internationally on medical research and health service transformation. He is Senior Independent Director at BUPA Chile and was until 2019 non-executive director of the BUPA main Board and the Chair of the Medical Advisory Council. He is the Chair of Collaboration for the Advancement of Medical Innovation (CASMI) UCL and Chaired the Oversight Group for the Academy of Medical Sciences project. He also served as an Review Board Member for Google Health (UK). Sir Tooke was Head of the School of Life and Medical Sciences at University College London (UCL) as Vice Provost (Health) and Academic Director of UCL Partners from 2010 - 2015. He is the Past President of the Academy of Medical Sciences in the UK. Sir Tooke has 30 years experience as a consultant physician specialising in diabetes, endocrinology, vascular medicine and internal medicine with research experience (basic biomedical, medicine, and health research and also includes improvement science) recognised through Fellowship of the Academy of Medical Sciences. He held a Board position at the Francis Crick Institute (2011 - 2015) and was a Member of the Council for Science & Technology (2011-2015) reporting to the Prime Minister (UK).
Dr Michael Winlo	Managing Director	Nov 2019	Dr Michael Winlo Managing Director Dr Winlo was CEO at Linear Clinical Research Ltd (Linear) until October 2019, a company that provides clinical trial services for US and Asia-based biotech companies. Linear adopt electronic data capture technology. Dr Winlo retains a Directorship at Linear. Prior to Linear, He was Health Lead at Palantir Technologies, a Big Data company based in Silicon Valley California.
Dr Alistair Vickery	Executive Director	Nov 2018	Dr Alistair Vickery Executive Director Dr Vickery has expertise in clinical practice, health service management, clinical and educational research and board director skills. He is adjunct Clinical Professor of Primary Health Care at the University of Western Australia and Notre Dame University. He is the clinical lead of the research group CHASM (The Collaborative for Health Care Analysis and Statistical Modelling) which provides analysis modelling to inform clinical service planning and service evaluation. He is Board Chair of Black Swan Health, one of NFP health care service providers in Western Australia.
Mr Matthew (Matt) Callahan	Non-Executive Director	Mar 2018	Mr Matthew (Matt) Callahan Non-Executive Director Mr Callahan is a life sciences executive with experience. He has been the founder, CEO or Executive Director of a number of pharmaceutical and health tech companies which includes Churchill Pharma Inc. He has led the development of four pharmaceutical products that have received FDA approval and he has more than 25 years legal, IP and investment management experience. Mr Callahan has worked as an investment director for two venture capital firms investing in lifesciences, technology and other sectors.
Dr Stewart James Washer	Executive Chairman,Executive Director	Mar 2018	Dr Stewart James Washer Executive Chairman,Executive Director Dr Washer has 25 years of CEO and Board experience in medical and agrifood biotech companies. Dr Washer has held a number of Board positions in the past which include Chairman of Hatchtech Pty Ltd and was a Director of iCeutica that was sold to a US Pharma. He was also a Senator with Murdoch University and was a Director of AusBiotech Ltd. Dr Washer was previously Chairman of Minomic International Ltd cancer diagnosis and treatment.
Mr Simon Lee Robertson	Company Secretary	N/A
Su-Mei Sain	Chief Financial Officer	N/A
Adam James	Chief Operating Officer	N/A

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
13/11/20	John Tooke	Issued	1,000,000	$0.076	$76,000	Issue of options
13/11/20	Matthew (Matt) Callahan	Issued	1,500,000	$0.076	$114,000	Issue of options
13/11/20	Alistair Vickery	Issued	2,000,000	$0.076	$152,000	Issue of options
13/11/20	Michael Winlo	Issued	4,000,000	$0.076	$304,000	Issue of options
12/11/20	Stewart Washer	Buy	+255,000	$0.08	$20,321	On-market trade
11/11/20	Stewart Washer	Buy	+150,000	$0.082	$12,283	On-market trade
10/11/20	Stewart Washer	Buy	+100,000	$0.08	$7,986	On-market trade
09/11/20	Stewart Washer	Buy	+270,000	$0.077	$20,765	On-market trade
19/10/20	Alistair Vickery	Buy	+128,000	$0.078	$10,002	On-market trade
16/03/20	Stewart Washer	Buy	+100,000	$0.061	$6,110	On-market trade
16/03/20	Stewart Washer	Buy	+100,000	$0.061	$6,110	On-market trade
10/03/20	Stewart Washer	Buy	+58,500	$0.09	$5,290	On-market trade
09/03/20	Stewart Washer	Buy	+120,500	$0.089	$10,668	On-market trade
06/03/20	Stewart Washer	Buy	+271,499	$0.089	$24,182	On-market trade
06/03/20	Stewart Washer	Buy	+271,499	$0.089	$24,182	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Alistair Vickery	13/11/2020	N/A	128,000	4,000,000	N/A
Michael Winlo	13/11/2020	N/A	N/A	7,500,000	N/A
John Tooke	13/11/2020	N/A	N/A	1,500,000	N/A
Matthew (Matt) Callahan	13/11/2020	N/A	19,600,000	1,500,000	N/A
Stewart Washer	12/11/2020	N/A	49,325,599	1,500,000	N/A

Show All

Top 20 Shareholders About the Data

Name	Shares	Capital
Stewart James Washer & Patrizia Derna Washer <The Washer Family A/C>	28,400,000	13.43%
Mal Washer Nominees Pty Ltd <Mal Washer Family No1 A/C>	19,600,000	9.27%
Mercator Shipwrights Pty Ltd <Mecator A/C>	19,600,000	9.27%
Mr Craig Lawrence Darby <Craig Lawrence Darby A/C>	19,600,000	9.27%
Lakevvest Pty Ltd <Raymond Desmond Family A/C>	5,160,532	2.44%
Mr Stephen Peter Somerville	4,900,000	2.32%
Mr Pak Lim Kong	3,416,667	1.62%
National Nominees Limited	2,600,000	1.23%
Mr Andrew Warren Simmons & Mrs Peta Sarah Lloyd Harris <Andeta Family A/C>	2,513,431	1.19%
Mr Craig Lawrence Darby	2,000,000	0.95%
Alexander Holdings (Wa) Pty Ltd	2,000,000	0.95%
Pac Partners Securities Pty Ltd	1,990,000	0.94%
D Schecter Medicine Professional Corporation	1,960,000	0.93%
Adam James <Araucariaa/C>	1,960,000	0.93%
Hsbc Custody Nominees (Australia) Limited	1,828,167	0.86%
Cann Group Limited	1,562,500	0.74%
Canopy Growth Corporation	1,562,500	0.74%
Baza High Conviction Pty Ltd <Baza High Conviction A/C>	1,398,431	0.66%
Mr Pak Lim Kong (I)	1,250,027	0.59%
Liddle Investments Group Pty Ltd <Liddle Super Fund A/C>	1,250,000	0.59%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$0.048	30 June

EMD Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.